These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 21883391)
1. Resolving actinic keratoses: an expected side-effect of capecitabine therapy. Al-Niaimi F; Lyon C Clin Exp Dermatol; 2012 Jan; 37(1):68-9. PubMed ID: 21883391 [No Abstract] [Full Text] [Related]
2. Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment. Peramiquel L; Dalmau J; Puig L; Roé E; Fernández-Figueras MT; Alomar A J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S119-20. PubMed ID: 17052530 [No Abstract] [Full Text] [Related]
3. [Resolution of actinic keratosis with capecetabin]. Schmutz JL; Trechot P Ann Dermatol Venereol; 2012 Nov; 139(11):759-60. PubMed ID: 23199778 [No Abstract] [Full Text] [Related]
4. Inflammation of actinic keratoses during capecitabine therapy. Lewis KG; Lewis MD; Robinson-Bostom L; Pan TD Arch Dermatol; 2004 Mar; 140(3):367-8. PubMed ID: 15023790 [No Abstract] [Full Text] [Related]
5. Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient. Aksoy S; Karaca B; Dinçer M; Yalçin S Ann Pharmacother; 2005 Mar; 39(3):573-4. PubMed ID: 15701780 [No Abstract] [Full Text] [Related]
6. Inflammation of actinic keratoses with capecitabine therapy for colon cancer. Serrão VV; Feio AB Eur J Dermatol; 2008; 18(2):200. PubMed ID: 18424393 [No Abstract] [Full Text] [Related]
7. Capecitabine-induced inflammation of actinic keratosis: case report and literature review. Stanciu M; Aubut N; Gagné E; Thibeault MM J Cutan Med Surg; 2012; 16(5):298-9. PubMed ID: 22971302 [No Abstract] [Full Text] [Related]
8. Capecitabine induced inflammation of actinic keratoses. Krathen M; Treat J; James WD Dermatol Online J; 2007 Oct; 13(4):13. PubMed ID: 18319010 [TBL] [Abstract][Full Text] [Related]
9. Dramatic response of recalcitrant warts as a side effect of colorectal cancer treatment with oral capecitabine. Bel B; Lorton MH; Darut-Jouve A; Vabres P Eur J Dermatol; 2011; 21(5):789-90. PubMed ID: 21700544 [No Abstract] [Full Text] [Related]
10. Successful treatment with low-dose capecitabine for disseminated esophageal adenocarcinoma. Carstens H; Albertsson M Acta Oncol; 2007; 46(6):866-8. PubMed ID: 17653915 [No Abstract] [Full Text] [Related]
17. Capecitabine as salvage therapy for a pancreatic cancer patient with extensive liver metastases and associated impairment of liver function. Saadati H; Saif MW JOP; 2008 May; 9(3):354-6. PubMed ID: 18469454 [No Abstract] [Full Text] [Related]
18. Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an elderly vitiligo patient. Tavares-Bello R J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1434-5. PubMed ID: 17958867 [No Abstract] [Full Text] [Related]
19. Dermatomyositis associated with capecitabine in the setting of malignancy. Chen FW; Zhou X; Egbert BM; Swetter SM; Sarin KY J Am Acad Dermatol; 2014 Feb; 70(2):e47-8. PubMed ID: 24438983 [No Abstract] [Full Text] [Related]
20. [Therapy traces on hands and feet in a patient with colon cancer]. Stiefelhagen P MMW Fortschr Med; 2012 Jun; O 154 Suppl 2():9. PubMed ID: 22916416 [No Abstract] [Full Text] [Related] [Next] [New Search]